Coldstream Capital Management Inc Tekla Life Sciences Investors Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Coldstream Capital Management Inc holds 39 shares of HQL stock, worth $507. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39Holding current value
$507% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HQL
# of Institutions
88Shares Held
9.21MCall Options Held
0Put Options Held
0-
Saba Capital Management, L.P. New York, NY3.43MShares$44.6 Million1.11% of portfolio
-
Penserra Capital Management LLC Orinda, CA747KShares$9.72 Million0.17% of portfolio
-
Karpus Management, Inc. Pittsford, NY468KShares$6.08 Million0.25% of portfolio
-
Morgan Stanley New York, NY366KShares$4.76 Million0.0% of portfolio
-
Needham Investment Management LLC New York, NY353KShares$4.59 Million0.4% of portfolio
About TEKLA LIFE SCIENCES INVESTORS
- Ticker HQL
- Exchange NYSE
- Sector Financial Services
- Industry Asset Management
- Description
- Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...